Copyright Reports & Markets. All rights reserved.

Global Tuberculosis Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tuberculosis Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Immune Vaccine
    • 1.3.3 Therapy Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tuberculosis Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Self-Procurement
    • 1.4.3 UNICEF
    • 1.4.4 Other
  • 1.5 Global Tuberculosis Vaccination Market Size & Forecast
    • 1.5.1 Global Tuberculosis Vaccination Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Tuberculosis Vaccination Sales Quantity (2020-2031)
    • 1.5.3 Global Tuberculosis Vaccination Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Tuberculosis Vaccination Product and Services
    • 2.1.4 Merck Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Japan BCG Lab
    • 2.2.1 Japan BCG Lab Details
    • 2.2.2 Japan BCG Lab Major Business
    • 2.2.3 Japan BCG Lab Tuberculosis Vaccination Product and Services
    • 2.2.4 Japan BCG Lab Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Japan BCG Lab Recent Developments/Updates
  • 2.3 Serum Institute of India
    • 2.3.1 Serum Institute of India Details
    • 2.3.2 Serum Institute of India Major Business
    • 2.3.3 Serum Institute of India Tuberculosis Vaccination Product and Services
    • 2.3.4 Serum Institute of India Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Serum Institute of India Recent Developments/Updates
  • 2.4 AJ Vaccines
    • 2.4.1 AJ Vaccines Details
    • 2.4.2 AJ Vaccines Major Business
    • 2.4.3 AJ Vaccines Tuberculosis Vaccination Product and Services
    • 2.4.4 AJ Vaccines Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 AJ Vaccines Recent Developments/Updates
  • 2.5 BioFarma
    • 2.5.1 BioFarma Details
    • 2.5.2 BioFarma Major Business
    • 2.5.3 BioFarma Tuberculosis Vaccination Product and Services
    • 2.5.4 BioFarma Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 BioFarma Recent Developments/Updates
  • 2.6 GreenSignal Bio Pharma
    • 2.6.1 GreenSignal Bio Pharma Details
    • 2.6.2 GreenSignal Bio Pharma Major Business
    • 2.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Product and Services
    • 2.6.4 GreenSignal Bio Pharma Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 GreenSignal Bio Pharma Recent Developments/Updates
  • 2.7 China National Biotec
    • 2.7.1 China National Biotec Details
    • 2.7.2 China National Biotec Major Business
    • 2.7.3 China National Biotec Tuberculosis Vaccination Product and Services
    • 2.7.4 China National Biotec Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 China National Biotec Recent Developments/Updates
  • 2.8 Biomed Lublin
    • 2.8.1 Biomed Lublin Details
    • 2.8.2 Biomed Lublin Major Business
    • 2.8.3 Biomed Lublin Tuberculosis Vaccination Product and Services
    • 2.8.4 Biomed Lublin Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biomed Lublin Recent Developments/Updates
  • 2.9 Taj Pharmaceuticals
    • 2.9.1 Taj Pharmaceuticals Details
    • 2.9.2 Taj Pharmaceuticals Major Business
    • 2.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Product and Services
    • 2.9.4 Taj Pharmaceuticals Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Taj Pharmaceuticals Recent Developments/Updates
  • 2.10 Ataulpho de Paiva
    • 2.10.1 Ataulpho de Paiva Details
    • 2.10.2 Ataulpho de Paiva Major Business
    • 2.10.3 Ataulpho de Paiva Tuberculosis Vaccination Product and Services
    • 2.10.4 Ataulpho de Paiva Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Ataulpho de Paiva Recent Developments/Updates
  • 2.11 IVAC – Institute of Vaccines and Medical Biologicals
    • 2.11.1 IVAC – Institute of Vaccines and Medical Biologicals Details
    • 2.11.2 IVAC – Institute of Vaccines and Medical Biologicals Major Business
    • 2.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product and Services
    • 2.11.4 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
  • 2.12 Queen Saovabha Mem. Inst
    • 2.12.1 Queen Saovabha Mem. Inst Details
    • 2.12.2 Queen Saovabha Mem. Inst Major Business
    • 2.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product and Services
    • 2.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
  • 2.13 Microgen
    • 2.13.1 Microgen Details
    • 2.13.2 Microgen Major Business
    • 2.13.3 Microgen Tuberculosis Vaccination Product and Services
    • 2.13.4 Microgen Tuberculosis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Microgen Recent Developments/Updates

3 Competitive Environment: Tuberculosis Vaccination by Manufacturer

  • 3.1 Global Tuberculosis Vaccination Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Tuberculosis Vaccination Revenue by Manufacturer (2020-2025)
  • 3.3 Global Tuberculosis Vaccination Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Tuberculosis Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Tuberculosis Vaccination Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Tuberculosis Vaccination Manufacturer Market Share in 2024
  • 3.5 Tuberculosis Vaccination Market: Overall Company Footprint Analysis
    • 3.5.1 Tuberculosis Vaccination Market: Region Footprint
    • 3.5.2 Tuberculosis Vaccination Market: Company Product Type Footprint
    • 3.5.3 Tuberculosis Vaccination Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tuberculosis Vaccination Market Size by Region
    • 4.1.1 Global Tuberculosis Vaccination Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Tuberculosis Vaccination Consumption Value by Region (2020-2031)
    • 4.1.3 Global Tuberculosis Vaccination Average Price by Region (2020-2031)
  • 4.2 North America Tuberculosis Vaccination Consumption Value (2020-2031)
  • 4.3 Europe Tuberculosis Vaccination Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Tuberculosis Vaccination Consumption Value (2020-2031)
  • 4.5 South America Tuberculosis Vaccination Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Tuberculosis Vaccination Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Tuberculosis Vaccination Sales Quantity by Type (2020-2031)
  • 5.2 Global Tuberculosis Vaccination Consumption Value by Type (2020-2031)
  • 5.3 Global Tuberculosis Vaccination Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Tuberculosis Vaccination Sales Quantity by Application (2020-2031)
  • 6.2 Global Tuberculosis Vaccination Consumption Value by Application (2020-2031)
  • 6.3 Global Tuberculosis Vaccination Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Tuberculosis Vaccination Sales Quantity by Type (2020-2031)
  • 7.2 North America Tuberculosis Vaccination Sales Quantity by Application (2020-2031)
  • 7.3 North America Tuberculosis Vaccination Market Size by Country
    • 7.3.1 North America Tuberculosis Vaccination Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Tuberculosis Vaccination Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Tuberculosis Vaccination Sales Quantity by Type (2020-2031)
  • 8.2 Europe Tuberculosis Vaccination Sales Quantity by Application (2020-2031)
  • 8.3 Europe Tuberculosis Vaccination Market Size by Country
    • 8.3.1 Europe Tuberculosis Vaccination Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Tuberculosis Vaccination Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tuberculosis Vaccination Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Tuberculosis Vaccination Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Tuberculosis Vaccination Market Size by Region
    • 9.3.1 Asia-Pacific Tuberculosis Vaccination Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Tuberculosis Vaccination Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Tuberculosis Vaccination Sales Quantity by Type (2020-2031)
  • 10.2 South America Tuberculosis Vaccination Sales Quantity by Application (2020-2031)
  • 10.3 South America Tuberculosis Vaccination Market Size by Country
    • 10.3.1 South America Tuberculosis Vaccination Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Tuberculosis Vaccination Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tuberculosis Vaccination Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Tuberculosis Vaccination Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Tuberculosis Vaccination Market Size by Country
    • 11.3.1 Middle East & Africa Tuberculosis Vaccination Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Tuberculosis Vaccination Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Tuberculosis Vaccination Market Drivers
  • 12.2 Tuberculosis Vaccination Market Restraints
  • 12.3 Tuberculosis Vaccination Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tuberculosis Vaccination and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tuberculosis Vaccination
  • 13.3 Tuberculosis Vaccination Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tuberculosis Vaccination Typical Distributors
  • 14.3 Tuberculosis Vaccination Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tuberculosis Vaccination market size was valued at US$ 82.6 million in 2024 and is forecast to a readjusted size of USD 101 million by 2031 with a CAGR of 2.9% during review period.
    Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
    The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
    This report is a detailed and comprehensive analysis for global Tuberculosis Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tuberculosis Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Tuberculosis Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Tuberculosis Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Tuberculosis Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tuberculosis Vaccination
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tuberculosis Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tuberculosis Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Immune Vaccine
    Therapy Vaccine
    Market segment by Application
    Self-Procurement
    UNICEF
    Other
    Major players covered
    Merck
    Japan BCG Lab
    Serum Institute of India
    AJ Vaccines
    BioFarma
    GreenSignal Bio Pharma
    China National Biotec
    Biomed Lublin
    Taj Pharmaceuticals
    Ataulpho de Paiva
    IVAC – Institute of Vaccines and Medical Biologicals
    Queen Saovabha Mem. Inst
    Microgen
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tuberculosis Vaccination product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tuberculosis Vaccination, with price, sales quantity, revenue, and global market share of Tuberculosis Vaccination from 2020 to 2025.
    Chapter 3, the Tuberculosis Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tuberculosis Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tuberculosis Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccination.
    Chapter 14 and 15, to describe Tuberculosis Vaccination sales channel, distributors, customers, research findings and conclusion.

    Buy now